B-type natriuretic peptide measurement in heart failure

Daniel M. Spevack, Arthur Schwartzbard

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.

Original languageEnglish (US)
Pages (from-to)489-494
Number of pages6
JournalClinical Cardiology
Issue number9
StatePublished - Sep 2004
Externally publishedYes


  • B-type natriuretic peptide
  • Diagnosis
  • Heart failure
  • Natriuretic
  • Prognosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'B-type natriuretic peptide measurement in heart failure'. Together they form a unique fingerprint.

Cite this